The drugmaker hopes to show CagriSema leads to at least 25% weight loss, without increased side effects. Its lead in a ...

In recent years, the medical community has been reevaluating traditional approaches to managing type 2 diabetes. A groundbreaking study has shed new light on ...

Adults with mild type 2 diabetes might improve their insulin sensitivity by following a low-carb diet, thus potentially ...

Approximately one in 10 Americans has diabetes, with 90–95% of these cases being type 2, making it one of the most common and ... to enhance understanding and treatment. Now, a new study ...

Antibiotics and other prescription drugs release hundreds of micropollutants into wastewater ... As a result, this method of purifying pharmaceutical-contaminated waters is surprisingly cost-effective ...

This number, such as 10%, is given in the account information. The effective annual return, on the other hand, accounts for intra-year compounding to give a more complete picture of how interest ...

SINGAPORE – Newer drugs ... diabetes are now gaining attention as potential treatments for a host of other medical problems, aside from their effects such as significant weight loss. The most ...

People living with type 2 diabetes may know all about metformin, which is an oral medication taken to manage this health condition. This medicine works by lowering blood sugar levels, improving ...

The size of the cardiac and anti-diabetes drugs market in India has more than tripled in the last 10 years, said the latest report from Pharmarack. The report said that the anti-diabetes market ...

Matthew Chapman is a video game designer who attended Rensselaer Polytechnic Institute and lives in San Marcos, Texas. Before joining Raw Story, he wrote for Shareblue and AlterNet, specializing ...

Newer weight loss drugs are cost effective in the long term only when ... Originally used to treat type 2 diabetes, liraglutide (branded as Saxenda) and, more recently, semaglutide (branded ...

Expanding access to new, highly effective weight ... with high obesity and diabetes rates, such as West Virginia, Mississippi, and Oklahoma, stand to benefit the most from increased medication ...